{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T01:14:50Z","timestamp":1782436490895,"version":"3.54.5"},"reference-count":27,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2004,12,1]],"date-time":"2004-12-01T00:00:00Z","timestamp":1101859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,12,1]],"date-time":"2004-12-01T00:00:00Z","timestamp":1101859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2004,12]]},"DOI":"10.1016\/j.ahj.2004.10.005","type":"journal-article","created":{"date-parts":[[2004,12,16]],"date-time":"2004-12-16T00:02:41Z","timestamp":1103155361000},"page":"971-978","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":81,"title":["Spironolactone-induced renal insufficiency and hyperkalemia in patients with heart failure"],"prefix":"10.1016","volume":"148","author":[{"given":"Kamala P.","family":"Tamirisa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith D.","family":"Aaronson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd M.","family":"Koelling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ahj.2004.10.005_BIB1","first-page":"209","article-title":"Treatment of cardiac edemas by a combination of micronized aldactone and altizide","volume":"4","author":"Soulie","year":"1965","journal-title":"Coeur et Medecine Interne"},{"key":"10.1016\/j.ahj.2004.10.005_BIB2","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure","volume":"341","author":"Pitt","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2004.10.005_BIB3","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1001\/archinte.1986.00360180240037","article-title":"Severe hyperkalemia as a complication of timolol, a topically applied beta-adrenergic antagonist","volume":"146","author":"Swenson","year":"1986","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ahj.2004.10.005_BIB4","first-page":"269","article-title":"Hyperkalemia associated with intravenous labetalol therapy for acute hypertension in renal transplant recipients","volume":"33","author":"Arthur","year":"1990","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.ahj.2004.10.005_BIB5","first-page":"E68","article-title":"Adrenergic modulation of potassium metabolism during exercise in normal and diabetic humans","volume":"252","author":"Castellino","year":"1987","journal-title":"Am J Physiol"},{"key":"10.1016\/j.ahj.2004.10.005_BIB6","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1001\/archinte.1977.03630200026010","article-title":"Potassium homeostasis in chronic diabetes mellitus","volume":"137","author":"Perez","year":"1977","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ahj.2004.10.005_BIB7","doi-asserted-by":"crossref","first-page":"732","DOI":"10.2337\/diab.27.7.732","article-title":"Aldosterone responsiveness in patients with diabetes mellitus","volume":"27","author":"Christlieb","year":"1978","journal-title":"Diabetes"},{"key":"10.1016\/j.ahj.2004.10.005_BIB8","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1001\/archinte.1989.00390060063013","article-title":"Hyperkalemia in diabetes mellitus","volume":"149","author":"Hollenberg","year":"1989","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ahj.2004.10.005_BIB9","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0891-6632(90)90057-C","article-title":"Hyperkalemia in diabetes mellitus","volume":"4","author":"Uribarri","year":"1990","journal-title":"J Diabetic Comp"},{"key":"10.1016\/j.ahj.2004.10.005_BIB10","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1016\/S0735-1097(01)01683-7","article-title":"ACC\/AHA guidelines for the evaluation and management of chronic heart failure in the adult","volume":"38","author":"Hunt","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2004.10.005_BIB11","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/S0002-9149(96)00465-1","article-title":"Effectiveness of spironolactone added to an angiotensin-converting enzyme inhibitor and a loop diuretic for severe chronic congestive heart failure","volume":"78","year":"1996","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ahj.2004.10.005_BIB12","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1161\/01.CIR.82.5.1730","article-title":"Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality","volume":"82","author":"Swedberg","year":"1990","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2004.10.005_BIB13","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1136\/pgmj.71.839.551","article-title":"Hyperkalaemia in diabetes: prevalence and associations","volume":"71","author":"Jarman","year":"1995","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.ahj.2004.10.005_BIB14","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0272-6386(85)80135-9","article-title":"Lethal hyperkalemia associated with severe hyperglycemia in diabetic patients with renal failure","volume":"5","author":"Montoliu","year":"1985","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ahj.2004.10.005_BIB15","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","article-title":"Eplerenone, a selective aldoste-rone blocker, in patients with left ventricular dysfunction after myocardial infarction","volume":"348","author":"Pitt","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2004.10.005_BIB16","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/0300-9572(86)90069-9","article-title":"Hyperkalemic cardiac arrest during an infusion of potassium chloride following an overdose of propranolol","volume":"14","author":"Cox","year":"1986","journal-title":"Resuscitation"},{"key":"10.1016\/j.ahj.2004.10.005_BIB17","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/S0002-9343(01)00642-8","article-title":"Life-threatening hyperkalemia during combined therapy with angiotensin-converting enzyme inhibitors and spironolactone: an analysis of 25 cases","volume":"110","author":"Schepkens","year":"2001","journal-title":"Am J Med"},{"key":"10.1016\/j.ahj.2004.10.005_BIB18","first-page":"315","article-title":"Elderly heart failure patients with drug-induced serious hyperkalemia","volume":"12","author":"Vanpee","year":"2000","journal-title":"Aging"},{"key":"10.1016\/j.ahj.2004.10.005_BIB19","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S0002-9149(02)02581-X","article-title":"Hyperkalemia in congestive heart failure patients aged 63 to 85 years with subclinical renal disease","volume":"90","author":"Obialo","year":"2002","journal-title":"Am J Card"},{"key":"10.1016\/j.ahj.2004.10.005_BIB20","doi-asserted-by":"crossref","first-page":"537","DOI":"10.2165\/00002018-200225070-00007","article-title":"Renal failure associated with the use of celecoxib and rofecoxib","volume":"25","author":"Ahmad","year":"2002","journal-title":"Drug Safety"},{"key":"10.1016\/j.ahj.2004.10.005_BIB21","first-page":"2133","article-title":"Nephrotoxicity of selective COX-2 inhibitors","volume":"28","author":"Woywodt","year":"2001","journal-title":"J Rheum"},{"key":"10.1016\/j.ahj.2004.10.005_BIB22","doi-asserted-by":"crossref","first-page":"23B","DOI":"10.1016\/S0002-9149(97)89236-3","article-title":"Indapamide is superior to thiazide in the preservation of renal function in patients with renal insufficiency and systemic hypertension","volume":"77","author":"Madkour","year":"1996","journal-title":"Am J Card"},{"key":"10.1016\/j.ahj.2004.10.005_BIB23","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/(SICI)1096-9136(199702)14:2<169::AID-DIA307>3.0.CO;2-5","article-title":"Life-threatening hyperkalaemia caused by angiotensin-converting enzyme-inhibitor and diuretics","volume":"14","author":"Odawara","year":"1997","journal-title":"Diab Med"},{"key":"10.1016\/j.ahj.2004.10.005_BIB24","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1172\/JCI10366","article-title":"The renal thiazide-sensitive Na-Cl cotransporter as mediator of the aldosterone-escape phenomenon","volume":"108","author":"Wang","year":"2001","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ahj.2004.10.005_BIB25","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1001\/jama.1973.03220280028007","article-title":"Adverse reactions to spironolactone. A report from the Boston collaborative drug surveillance program","volume":"225","author":"Greenblatt","year":"1973","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2004.10.005_BIB26","doi-asserted-by":"crossref","first-page":"E8","DOI":"10.1136\/heart.85.4.e8","article-title":"Serious adverse events experienced by patients with chronic heart failure taking spironolactone","volume":"85","author":"Berry","year":"2001","journal-title":"Heart"},{"key":"10.1016\/j.ahj.2004.10.005_BIB27","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1016\/S0140-6736(05)72606-4","article-title":"Spironolactone and congestive heart-failure","volume":"355","author":"Georges","year":"2000","journal-title":"Lancet"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870304007501?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870304007501?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T05:11:23Z","timestamp":1757567483000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870304007501"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,12]]},"references-count":27,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2004,12]]}},"alternative-id":["S0002870304007501"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2004.10.005","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2004,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Spironolactone-induced renal insufficiency and hyperkalemia in patients with heart failure","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2004.10.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}